임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 2상모집 중· Upper Limb Essential TremorStudy of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Essential Tremor
리드: 애브비
- 2상모집 중· Chronic Lymphocytic Leukemia (CLL)Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab
리드: 아스트라제네카 · 협력: 애브비, 로슈
- 1상모집 중· Healthy VolunteersA Phase 1 Study to Assess the Effect of Itraconazole on ABBV-722 in Healthy Adult Participants
리드: 애브비
- 2/3상모집 중· Metastatic Pancreatic Ductal AdenocarcinomaA Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal Adenocarcinoma
리드: 애브비
- 단계 미표기모집 중· Hepatitis C Virus (HCV)Study of Glecaprevir/Pibrentasvir to Assess Safety Through Real-World Data
리드: 애브비
- 2상모집 중· Lung Non-Small Cell CarcinomaTelisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer
협력: 애브비
- 2상모집 중· Idiopathic Pulmonary FibrosisStudy of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
리드: 애브비
- 2/3상모집 중· Multiple MyelomaA Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
리드: 애브비
- 2상모집 중· Major Depressive DisorderA Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
리드: 애브비
- 1상모집 중· Healthy VolunteersA Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.
리드: 애브비
- 2상모집 중· Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm Patients
협력: 애브비
- 2/3상모집 중· Non-Small Cell Lung CancerA Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
리드: 애브비
- 2상모집 중· Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)Venetoclax as Consolidation in CLL Patients Treated With BTK Inhibitor Monotherapy
협력: 애브비
- 2상모집 중· Small Cell Lung CancerA Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
리드: 애브비
- 2상모집 중· Epithelial Ovarian CancerA Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
리드: 애브비
- 단계 미표기모집 중· Advanced Parkinson's DiseaseA Study to Assess Change in Sleep Disturbances of Adult Participants With Advanced Parkinson's Disease Receiving Subcutaneous Foslevodopa/Foscarbidopa
리드: 애브비
- 2상모집 중· Waldenstrom MacroglobulinemiaA Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
협력: 애브비, 일라이 릴리
- 3상모집 중· Neovascular Age-related Macular DegenerationStudy to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
리드: 애브비
- 1상모집 중· Healthy VolunteerA Study to Assess the Adverse Events and How Oral ABBV-1042 Moves Through the Body of Healthy Adult Participants
리드: 애브비
- 2상모집 중· Marginal Zone LymphomaEpcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)
협력: 애브비
- 2상모집 중· Bipolar I or II DisorderStudy to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder
리드: 애브비
- 2상모집 중· Primary CNS Lymphoma (PCNSL)Study of Epcoritamab in R/R Primary Diffuse Large B-cell Lymphoma of the CNS Treated With Lenalidomide and Rituximab
협력: 애브비
- 2상모집 중· Intensive Chemotherapy UnfitAlternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML
협력: 애브비
- 단계 미표기모집 중· Non-Segmental Vitiligo (NSV)A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa
리드: 애브비
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.